Latest filing published 03 Mar 2026 for Aurinia Pharmaceuticals Inc., €453k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -12.4%Entry US$11.29 · Close at T+365 US$9.89
- -38.9%Entry US$12,672.00 · Close at T+365 US$7,747.20
- -54.8%Entry US$15,552.00 · Close at T+365 US$7,027.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Joseph M. Miller: trading record in brief
This profile gathers the share dealings of Joseph M. Miller across 2 companies, led by Aurinia Pharmaceuticals Inc. and Avalo Therapeutics, Inc. Between 12 July 2018 and 2 March 2026, the trades on record add up to 23 filings.
Market trades split into 3 purchases (€18k) and 6 sales (€1.3M). On balance, insiders were net sellers of €1.3M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 14 share grants.
A typical purchase (the median) is worth €6,692. Clusters matter here: 2 out of 3 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 3 purchases show a median change of -36.9%, with the price up in 33% of them. Past outcomes like these are no guarantee of what comes next.
The record was last updated on 3 March 2026 with a share grant (€453k) in Aurinia Pharmaceuticals Inc. The last insider purchase was made public on 11 May 2021, 2,008 days ago. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Joseph M. Miller
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 37,511 shares@ US$14.2116.8% of flowCommon StockSEC:0001600620-26-000023:1
- 57,229 shares0Common StockSEC:0001600620-26-000023:0
- 32,424 shares@ US$14.4058.5% of flowCommon StockSEC:0001746372-26-000002:0
- 40,161 shares@ US$15.9520.2% of flowCommon StockSEC:0001600620-26-000003:1
- 49,038 shares0Common StockSEC:0001600620-26-000003:0
- 114,711 shares0Common StockSEC:0001600620-25-000020:1
- 61,859 shares@ US$8.0017.6% of flowCommon StockSEC:0001600620-25-000020:2
- 56,154 shares@ US$7.9215.7% of flowCommon StockSEC:0001600620-25-000020:3
- 81,457 shares0Common StockSEC:0001600620-25-000020:0
- 34,811 shares@ US$5.6026.5% of flowCommon StockSEC:0001600620-24-000037:0
- 196,153 shares0Common StockSEC:0001600620-24-000018:0
- 11,398 shares@ US$8.7813.8% of flowCommon StockSEC:0001600620-24-000014:0
- 11,296 shares@ US$8.943.5% of flowCommon StockSEC:0001628280-23-006531:1
- 229,421 sharesCommon StockSEC:0001628280-23-006531:0
- 3,060 shares@ US$12.011.2% of flowCommon StockSEC:0001628280-22-005127:1
- 8,500 shares0Common StockSEC:0001628280-22-005127:0
- 1,000 shares@ US$9.741.2% of flowCommon StockSEC:0001628280-21-009835:0Canonical exit: 9 Aug 2021 (T+90)
- 4,472 shares@ US$3.2235.9% of flowCommon StockSEC:0001192482-20-000479:0
- 45,000 shares0Common StockSEC:0001578563-20-000018:0
- 3,723 shares@ US$4.8545.2% of flowCommon StockSEC:0001578563-20-000015:0
- 2,598 shares@ US$2.8517.4% of flowCommon StockSEC:0001578563-19-000039:0Canonical exit: 9 Mar 2020 (T+90)
- 1,179 shares@ US$2.857.7% of flowCommon StockSEC:0001578563-19-000022:0Canonical exit: 8 Sept 2019 (T+90)
- 45,000 shares0Common StockSEC:0001746282-18-000004:0
23 of 23 declarations
